Then, since sitagliptin increased GLP-1 plasma levels (Figure 3a) and reduced myocardial fibrosis in GK rats (Figure 2a), we assayed whether GLP-1 may modulate the pro-fibrotic response to HF and HG in cardiomyocytes. The gene discussed is GCG; the disease is Myocardial fibrosis.